Asia-Pacific Journal of Ophthalmology
短名 | Asia Pac J Ophthalmol (Phila) |
Journal Impact | 3.80 |
国际分区 | OPHTHALMOLOGY(Q1) |
期刊索引 | SCI Q1中科院 3 区 |
ISSN | 2162-0989 |
h-index | 40 |
国内分区 | 医学(3区)医学眼科学(2区) |
The Asia-Pacific Journal of Ophthalmology, a bimonthly, peer-reviewed online scientific publication, is an official publication of the Asia-Pacific Academy of Ophthalmology (APAO), a supranational organization which is committed to research, training, learning, publication and knowledge and skill transfers in ophthalmology and visual sciences. The Asia-Pacific Journal of Ophthalmology welcomes review articles on currently hot topics, original, previously unpublished manuscripts describing clinical investigations, clinical observations and clinically relevant laboratory investigations, as well as .perspectives containing personal viewpoints on topics with broad interests. Editorials are published by invitation only. Case reports are generally not considered. The Asia-Pacific Journal of Ophthalmology covers 16 subspecialties and is freely circulated among individual members of the APAO’s member societies, which amounts to a potential readership of over 50,000.
期刊主页涉及主题 | 医学生物眼科外科心理学物理光学内科学神经科学病理化学验光服务遗传学生物化学视力精神科植物 |
出版信息 | 出版商: Elsevier B.V.,出版周期: ,期刊类型: journal |
基本数据 | 创刊年份: 2015,原创研究文献占比: 45.28%,自引率:0.00%, Gold OA占比: 98.33% |
平均审稿周期 | 网友分享经验:6 Weeks |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Latest Developments of Generative Artificial Intelligence and Applications in Ophthalmology
2024-8-1
A review of ophthalmology education in the era of generative artificial intelligence
2024-8-1
Development of Oculomics Artificial Intelligence for Cardiovascular Risk Factors: A Case Study in Fundus Oculomics for HbA1c Assessment and Clinically Relevant Considerations for Clinicians
2024-8-1
Cybersecurity in the Generative Artificial intelligence Era
2024-8-1
Upholding Artificial Intelligence Transparency in Ophthalmology: A Call for Collaboration between Academia, Industry, and Government for Patient Care in the 21st Century
2024-8-1
Longitudinal imaging of 8-year progression in a teenager with Stargardt disease
2024-8-1
Artificial intelligence for Retinal Diseases
2024-8-1
Development and testing of Artificial Intelligence based mobile application to achieve cataract backlog-free status in Uttar Pradesh, India
2024-8-1
An unusual iris in Waardenburg syndrome
2024-7-1
The role of saliency maps in enhancing ophthalmologists’ trust in artificial intelligence models
2024-7-1
Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives
2024-7-1
Natural Language Processing in medicine and ophthalmology: A review for the 21st-century clinician
2024-7-1
Response: Comment on "Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination"
2024-7-1
Deep Learning‐Enabled Vasculometry Depicts Phased Lesion Patterns in High Myopia Progression
2024-7-1
Understanding natural language: Potential application of large language models to ophthalmology
2024-7-1
Diversity, equity and inclusion in curriculum vitae for medical and surgical specialty training college entrance
2024-7-1
Comment on “Update on coronavirus disease 2019: Ophthalmic manifestations and adverse reactions to vaccination”
2024-6-1
Transition probabilities of diabetic retinopathy and death in an Asian population with Diabetes
2024-5-1
Response: Comment on “Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial”
2024-5-1
Syphilitic scleritis and episcleritis: A review
2024-5-1
Comment on “Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial”
2024-5-1
Response to Letter to the Editor: “Discrepancies in reported prevalence rates of keratoconus in Russia”
2024-5-1
Diabetic retinopathy
2024-5-1
Association of baseline factors with 1-year outcomes in the SB11-ranibizumab equivalence trial: A post hoc analysis
2024-5-1
Cost-effectiveness of diabetic retinopathy screening for newly diagnosed type 2 diabetic patients: A nationwide population-based propensity score-matched cohort study
2024-5-1
Discrepancies in Reported Prevalence Rates of Keratoconus in Russia
2024-5-1
Etiology including epigenetic defects of retinoblastoma
2024-5-1
Risk factors for diabetic retinopathy, diabetic macular edema, and sight-threatening diabetic retinopathy
2024-5-1
Genetic Association of TIE2 with Diabetic Retinopathy and Diabetic Macular Edema
2024-5-1
Immediate versus Delayed sequential bilateral ICL implantation: a retrospective comparison of vault height and visual outcomes
2024-5-1
Long-term Efficacy and Safety of Posterior Endoscopic Cyclophotocoagulation in Refractory Glaucoma: A 5-Year Follow-up Study at a Tertiary Eye Center
2024-5-1
Exaggerated Immune Response to Fungal Keratitis Post-COVID-19 Vaccination
2024-4-1
Concealed retro-iridic multi-cavitary melanoma revealed by ultrasound biomicroscopy
2024-3-18
Navigating the Spectrum: A Comprehensive Exploration of Diverse Ocular and Orbital Tumor Entities
2024-3-1
Diffuse preretinal vitreous seeding as a recurrence of uveal melanoma
2024-3-1
Vitreous metastasis from cutaneous melanoma while on checkpoint inhibitors
2024-3-1
Intravascular Large B-cell Lymphoma of the Eye: Literature Review and New Findings
2024-3-1
Targeted Therapy in Ophthalmic Oncology: The Current Status
2024-3-1
Masquerade Syndrome: A Review of Uveitic Imposters
2024-3-1
Updates on eyelid cancers
2024-3-1
Metastatic renal cell carcinoma masquerading as an endogenous endophthalmitis: Role of vitreous cytology
2024-3-1
UVEAL MELANOMA: CURRENT EVIDENCE ON PROGNOSIS, TREATMENT AND POTENTIAL DEVELOPMENTS
2024-3-1
Recent progress in Retinoblastoma: Pathogenesis, Presentation, Diagnosis and Management
2024-3-1
Bilateral Diffuse Uveal Melanocytic Proliferation Secondary to Combined Hepatocellular-cholangiocarcinoma
2024-3-1
Topical 5-fluorouracil 1% for Moderate to Extensive Ocular Surface Squamous Neoplasia in 73 Consecutive Patients: Primary Versus Secondary Treatment
2024-3-1
Update on Chemotherapy Modalities for Retinoblastoma: Progress and Challenges
2024-3-1
An optimized 3T MRI scan protocol to assess iris melanoma with subsequent histopathological verification – a prospective study
2024-2-1
Correlation of fitzpatrick skin type and iris color with tumor size in 823 patients with uveal melanoma
2024-2-1
Subretinal drusenoid deposits, age-related macular degeneration, and cardiovascular disease
2024-1-1
Perioperative intense pulsed light to prevent and improve symptoms of post-laser corneal refractive surgery dry eye. A randomized clinical trial
2024-1-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远